Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs744051 | chr12:56667298 | C/T | 9.28E-8 | 178 | 0.8 | 27.33 | 25.08 | KM Plot |
PCPG | rs74437292 | chr10:131549953 | ATTT/A | 7.48E-6 | 176 | 25 | 27.27 | 14.25 | KM Plot |
PCPG | rs74456459 | chr2:61578601 | TA/T | 6.1E-5 | 178 | 24.1 | 30.18 | 10.3 | KM Plot |
PCPG | rs74457055 | chr8:53842669 | T/G | 0.000433 | 173 | 24.47 | 27.27 | 6.1 | KM Plot |
PCPG | rs74459344 | chr3:53099595 | A/G | 7.69E-6 | 175 | 25.08 | 26.57 | 11.78 | KM Plot |
PCPG | rs74464266 | chr17:80514914 | A/T | 4.21E-5 | 178 | 25.97 | 19.72 | 7.2 | KM Plot |
PCPG | rs74496027 | chr12:56726340 | C/T | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs74513657 | chr3:53336459 | A/G | 0.000189 | 178 | 25.17 | 39.3 | 26.73 | KM Plot |
PCPG | rs7452300 | chr6:131714738 | C/T | 5.68E-6 | 178 | 25 | 27.2 | 17.8 | KM Plot |
PCPG | rs74532786 | chr2:176133280 | T/C | 0.000152 | 174 | 25.4 | 28.47 | 6.62 | KM Plot |
PCPG | rs74542234 | chr16:89940608 | A/C | 0.000194 | 174 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs74571727 | chr2:237535062 | C/T | 1.11E-16 | 170 | 25.17 | 24.77 | 3.17 | KM Plot |
PCPG | rs74581045 | chr2:118529724 | A/C | 1.76E-5 | 177 | 25.4 | 28.45 | 11.65 | KM Plot |
PCPG | rs74673257 | chr12:56638077 | T/C | 9.68E-8 | 178 | 25.17 | 29.13 | 0.8 | KM Plot |
PCPG | rs746857 | chr2:136554890 | G/A | 3.21E-5 | 174 | 9.72 | 24.1 | 25.67 | KM Plot |